The 17-building rental portfolio from Holsten Real Estate Development Corp. is likely to generate strong interest from buyers as demand for affordable housing remains high.
AbbVie confirmed this morning it will acquire Apogee Therapeutics for $10.9 billion, boosting its immunology business and giving it a foothold in the asthma treatment space.